Complex Management Decisions in a Professional Athlete With Recurrent Pericarditis
- PMID: 36124145
- PMCID: PMC9481902
- DOI: 10.1016/j.jaccas.2022.05.015
Complex Management Decisions in a Professional Athlete With Recurrent Pericarditis
Abstract
A 32-year-old professional athlete developed chronic recurrent pericarditis despite standard medical therapy. Etiology included postpericardiotomy syndrome, viral, or COVID-19 vaccine related, all potentially exacerbated by intense exercise. Treatment and return-to-play decisions were complicated by potential side-effect profile of therapies and ability to limit exercise as a professional athlete. (Level of Difficulty: Intermediate.).
Keywords: CMR, cardiac magnetic resonance; COVID-19; CTS, cardiothoracic surgery; IL, interleukin; NSAID, nonsteroidal anti-inflammatory medication; athlete; exercise; pericarditis; postpericardiotomy; recurrence.
© 2022 The Authors.
Conflict of interest statement
Dr Roselli is a consultant and investigator for Edwards Lifesciences and Terumo Aortic. Dr Klein has received a research grant from and is on the advisory board for Kiniksa; and is on the advisory board for Cardiol Therapeutics and Pfizer. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
